Chromosome 2 Fragment Substitutions in Dahl Salt-Sensitive Rats and RNA Sequencing Identified


Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
01 2021
Historique:
pubmed: 10 11 2020
medline: 7 7 2021
entrez: 9 11 2020
Statut: ppublish

Résumé

Chromosome 2 introgression from normotensive Brown Norway (BN) rats into hypertensive Dahl salt-sensitive (SS) background (SS-chromosome 2

Identifiants

pubmed: 33161775
doi: 10.1161/HYPERTENSIONAHA.120.15690
pmc: PMC7726001
mid: NIHMS1633374
doi:

Substances chimiques

Sodium Chloride, Dietary 0
Sulfotransferases EC 2.8.2.-
heparan-sulfate 2-sulfotransferase EC 2.8.2.-
Glutamyl Aminopeptidase EC 3.4.11.7

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

178-189

Subventions

Organisme : NHLBI NIH HHS
ID : U01 HL066579
Pays : United States
Organisme : CIHR
ID : 123465
Pays : Canada
Organisme : CIHR
ID : 143348
Pays : Canada

Commentaires et corrections

Type : CommentIn

Références

J Hypertens. 2018 Mar;36(3):641-650
pubmed: 28968260
Nat Genet. 2016 Oct;48(10):1151-1161
pubmed: 27618447
Clin Sci (Lond). 2014 Aug;127(3):135-48
pubmed: 24697296
Mol Med. 2003 Jan-Feb;9(1-2):57-62
pubmed: 12765341
Int J Mol Sci. 2019 Nov 07;20(22):
pubmed: 31703282
Nature. 2007 Apr 26;446(7139):1030-7
pubmed: 17460664
J Biol Chem. 1992 May 25;267(15):10337-41
pubmed: 1587820
Physiol Genomics. 2005 May 11;21(3):362-9
pubmed: 15741507
BMC Proc. 2014 Jun 17;8(Suppl 1):S73
pubmed: 25519343
J Clin Hypertens (Greenwich). 2008 Jun;10(6):459-66
pubmed: 18550936
Nature. 2011 Aug 31;477(7362):54-60
pubmed: 21886157
J Mol Cell Cardiol. 2010 Aug;49(2):287-93
pubmed: 20206635
Glycoconj J. 2002 May-Jun;19(4-5):347-54
pubmed: 12975615
Physiol Genomics. 2006 Aug 16;26(3):218-25
pubmed: 16772359
Hypertension. 2012 Aug;60(2):411-8
pubmed: 22710644
Mamm Genome. 2002 Jan;13(1):41-4
pubmed: 11773968
Am J Physiol Renal Physiol. 2009 Aug;297(2):F301-6
pubmed: 19493966
Biochem Soc Trans. 2000;28(4):435-40
pubmed: 10961935
Tissue Antigens. 1993 Nov;42(5):488-96
pubmed: 8146860
Acta Physiol Scand. 2004 Aug;181(4):585-92
pubmed: 15283774
Methods Mol Biol. 2010;597:243-66
pubmed: 20013238
Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H938-44
pubmed: 20044442
Peptides. 2020 Jan;123:170204
pubmed: 31738968
Blood. 2012 Aug 23;120(8):1742-51
pubmed: 22791291
J Hypertens. 2006 Feb;24(2):325-30
pubmed: 16508580
Pharmacol Rep. 2020 Feb;72(1):246-253
pubmed: 32016850
Br J Haematol. 2009 May;145(3):350-68
pubmed: 19298595
Int Rev Cell Mol Biol. 2016;325:215-73
pubmed: 27241222
Nat Commun. 2016 Sep 27;7:13035
pubmed: 27676657
J Physiol. 2004 Jan 1;554(Pt 1):46-55
pubmed: 14678490
Clin Exp Hypertens. 2015;37(7):580-6
pubmed: 25992486
Development. 2010 Jul;137(13):2187-96
pubmed: 20530546
Nat Genet. 2016 Oct;48(10):1171-1184
pubmed: 27618452
Am J Physiol Heart Circ Physiol. 2019 Aug 1;317(2):H279-H289
pubmed: 31150271
J Clin Invest. 1994 Jul;94(1):431-6
pubmed: 8040284
Br J Pharmacol. 2019 Jun;176(12):1818-1828
pubmed: 29952002
Am J Physiol Renal Physiol. 2008 Sep;295(3):F837-42
pubmed: 18653478
Hypertension. 2020 Jan;75(1):6-15
pubmed: 31786978
Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2666-72
pubmed: 19011014
Heart Fail Rev. 2008 Sep;13(3):273-84
pubmed: 17990103
Nat Genet. 2011 Jun;43(6):531-8
pubmed: 21572416
Atherosclerosis. 2004 Jul;175(1):51-7
pubmed: 15186946
Genes Dev. 1998 Jun 15;12(12):1894-906
pubmed: 9637690
Physiol Genomics. 2002 Sep 03;10(3):199-210
pubmed: 12209022
Proc Natl Acad Sci U S A. 1990 Feb;87(3):993-7
pubmed: 1689065
J Cell Sci. 2002 May 1;115(Pt 9):1951-9
pubmed: 11956326
FEBS Lett. 2014 Apr 17;588(8):1238-43
pubmed: 24656738
Am J Hypertens. 2005 Apr;18(4 Pt 1):538-43
pubmed: 15831365
Horm Metab Res. 2008 Dec;40(12):887-91
pubmed: 18726831

Auteurs

Olga Berillo (O)

From the Vascular and Hypertension Research Unit, Lady Davis Institute for Medical Research (O.B., S.O., N.I.-K., A.R., P.P., E.L.S.).

Sofiane Ouerd (S)

From the Vascular and Hypertension Research Unit, Lady Davis Institute for Medical Research (O.B., S.O., N.I.-K., A.R., P.P., E.L.S.).

Noureddine Idris-Khodja (N)

From the Vascular and Hypertension Research Unit, Lady Davis Institute for Medical Research (O.B., S.O., N.I.-K., A.R., P.P., E.L.S.).

Asia Rehman (A)

From the Vascular and Hypertension Research Unit, Lady Davis Institute for Medical Research (O.B., S.O., N.I.-K., A.R., P.P., E.L.S.).

Chantal Richer (C)

Sainte-Justine University Hospital, Montreal, QC, Canada (C.R., D.S.).

Daniel Sinnett (D)

Sainte-Justine University Hospital, Montreal, QC, Canada (C.R., D.S.).

Anne E Kwitek (AE)

Department of Physiology, Medical College of Wisconsin, Milwaukee (A.E.K.).

Pierre Paradis (P)

From the Vascular and Hypertension Research Unit, Lady Davis Institute for Medical Research (O.B., S.O., N.I.-K., A.R., P.P., E.L.S.).

Ernesto L Schiffrin (EL)

Department of Medicine (E.L.S.), Sir Mortimer B. Davis-Jewish General Hospital, McGill University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH